Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 17 , ISSUE 4 ( August, 2013 ) > List of Articles


Metabolic alkalosis: A less appreciated side effect of Imipenem-cilastatin use

Pragyan Swagatika Panda, Surya Kumar Dube, Suman Sarkar, Dinesh Kumar Singh

Citation Information : Panda PS, Dube SK, Sarkar S, Singh DK. Metabolic alkalosis: A less appreciated side effect of Imipenem-cilastatin use. Indian J Crit Care Med 2013; 17 (4):263-264.

DOI: 10.4103/0972-5229.118411

License: CC BY-ND 3.0

Published Online: 01-07-2014

Copyright Statement:  Copyright © 2013; The Author(s).


PDF Share
  1. Edwards SJ, Emmas CE, Campbell HE. Systematic review comparing meropenem with imipenem plus cilastatin in the treatment of severe infections. Curr Med Res Opin 2005;21:785-94.
  2. Galla JH. Metabolic alkalosis. J Am Soc Nephrol 2000;11:369-75.
  3. Brunner FP, Frick PG. Hypokalemia, metabolic alkalosis and hypernatremia due to massive sodium penicillin therapy. Br Med J 1968;30:550-2.
  4. Bhagwat A, Goel N, Sharma R, Jain S, Dua K. Meropenem: A unusual cause of metabolic alkalosis in critical care patients. Anaesth Intensive Care 2008;36:745-6.
  5. Zaki SA, Shanbag P. Meropenem induced hypokalemia and metabolic alkalosis. Indian J Pharmacol 2012;44:276-7.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.